Vaccination Program Appears to Reduce Respiratory Infections Among Recruits

From U.S. Navy Bureau of Medicine and Surgery Public Affairs

According to a Navy News Service article by Jonathan E. Friedman, Naval Medical Center Portsmouth Public Affairs, the results of giving adenovirus vaccinations to U.S. Navy recruits last October were released Jan. 30, and looked positive.

After a 10-year manufacturing hiatus, the Captain James A. Lovell Federal Health Care Center (FHCC) reinstituted giving the vaccine to minimize the symptoms of febrile upper respiratory infection.

The average number of infection cases among recruits in 2010 was 93 per week. In 2011, the average was 87 per week. In the first month of 2012, that average was reduced to 23 per week.

In the first week following the vaccination, the rate of febrile upper respiratory infections went from 105 to 63 cases. The next week, it went to 26. After that, there were only 11 recruits who were treated for febrile upper respiratory infection. The vaccine had effectively cut the number of cases by 89.5 percent.

For the entire article visit,